Daniel Kripke, M.D.
Daniel F. Kripke, M.D. is a licensed physician certified by the American Board of Psychiatry and Neurology and an Emeritus Professor of Psychiatry at the University of California, San Diego. He also has done research with the Scripps Clinic Viterbi Family Sleep Center. Dr. Kripke was elected a Fellow of the American Psychiatric Association, co-authored hundreds of medical articles and has given invited lectures in 18 countries. In 1973, Dr. Kripke established one of the first sleep clinics in the United States. He treated patients with sleep disorders until retirement from his clinical practice at age 70. Dr. Kripke continues to be active as a researcher and as an advocate for raising awareness of the dangers associated with sleeping pills, particularly hypnotic drugs.
Dr. Kripke’s research has shown that hypnotic drugs, especially certain benzodiazepines and Z drugs with similar actions on the brain, have the potential to cause infection, depression, and are associated with increased risk of death and cancer. Dr. Kripke’s desire in joining Benzodiazepine Information Coalition is to inform the public about the grave risks of these drugs.
Learn more about Dr. Kripke’s research at The Dark Side of Sleeping Pills.
- Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
- What do hypnotics cost hospitals and healthcare?
- Do hypnotic drugs cause cancer, like cigarettes?
- Possibility that certain hypnotics might cause cancer in skin.
- I petitioned the FDA to restrict hypnotics: here is why.
- Mortality Risk of Hypnotics: Strengths and Limits of Evidence.
- “Rebound” is not an appropriate criterion for withdrawal insomnia.
- Hypnotics cause insomnia: evidence from clinical trials.
- Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem.
NOTE: Dr. Kripke is responding to a study by Elisabetta Patorno, Robert J Glynn, Raisa Levin, Moa P Lee, and Krista F Huybrechts entitled Benzodiazepines and risk of all cause mortality in adults: cohort study. To date, Dr. Kripke's questions have not been addressed....read more
Chairs and Members of the Committee on Mental Health and Substance Abuse Massachusetts Legislature Dear Friends: The Benzodiazepine Information Coalition asked me to send you a letter in support of Bill H.3594 that I understand you are considering. I am a research...read more
Abstract: Abstract Hypnotics (sleeping pills) are prescribed widely, but the economic costs of the harm they have caused have been largely unrecognized. Randomized clinical trials have observed that hypnotics increase the incidence of infections. Likewise, hypnotics...read more
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit [version 2; referees: 2 approved]
This is a review of hypnotic drug risks and benefits, reassessing and updating advice presented to the Commissioner of the Food and Drug Administration (United States FDA). Almost every month, new information appears about the risks of hypnotics (sleeping pills). The...read more